BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25695570)

  • 1. But is it safe? Hydroxyethyl starch in perioperative care.
    Greenberg S; Tung A
    Anesth Analg; 2015 Mar; 120(3):519-521. PubMed ID: 25695570
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of 6% hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy: a randomized controlled trial.
    Kancir ASP; Johansen JK; Ekeloef NP; Pedersen EB
    Anesth Analg; 2015 Mar; 120(3):608-618. PubMed ID: 25627076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review.
    Hand WR; Whiteley JR; Epperson TI; Tam L; Crego H; Wolf B; Chavin KD; Taber DJ
    Anesth Analg; 2015 Mar; 120(3):619-626. PubMed ID: 25036375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hydroxyethyl starch for volume replacement therapy - a swan song?].
    Ittner KP
    Dtsch Med Wochenschr; 2013 Nov; 138(48):2450. PubMed ID: 24254341
    [No Abstract]   [Full Text] [Related]  

  • 5. Starch solutions in Australia: the empire strikes back.
    Bellomo R
    Crit Care Resusc; 2013 Dec; 15(4):253-4. PubMed ID: 24289503
    [No Abstract]   [Full Text] [Related]  

  • 6. Why hydroxyethyl starch solutions should NOT be banned from the operating room.
    De Hert S; De Baerdemaeker L
    Anaesthesiol Intensive Ther; 2014; 46(5):336-41. PubMed ID: 25432553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyethyl-starch use and PBM: a necessary update to the Italian national guidelines.
    Biancofiore G; Vaglio S; Liumbruno GM
    Blood Transfus; 2016 May; 14(2):195-6. PubMed ID: 27177414
    [No Abstract]   [Full Text] [Related]  

  • 8. Is fluid resuscitation with high-volume hydroxyethyl starch safe for the kidney in trauma patients?
    Xue FS; Liu GP; Li RP; Sun C
    Injury; 2015 Aug; 46(8):1698-9. PubMed ID: 25823537
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Gosling P; Rittoo D; Manji M; Mahmood A; Vohra R
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526921
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Godet G
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526922
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Boldt J
    Lancet; 2001 Aug; 358(9281):581-3. PubMed ID: 11526920
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the literature inconclusive about the harm from HES? Yes.
    Ertmer C; Annane D; Van Der Linden P
    Intensive Care Med; 2017 Oct; 43(10):1520-1522. PubMed ID: 27007102
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient.
    De Labarthe A; Jacobs F; Blot F; Glotz D
    Am J Med; 2001 Oct; 111(5):417-8. PubMed ID: 11599525
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.
    Kammerer T; Klug F; Schwarz M; Hilferink S; Zwissler B; von Dossow V; Karl A; Müller HH; Rehm M
    Trials; 2015 Aug; 16():384. PubMed ID: 26314293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the literature inconclusive about the harm from HES? No.
    Wiedermann CJ; Bellomo R; Perner A
    Intensive Care Med; 2017 Oct; 43(10):1523-1525. PubMed ID: 27007101
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis.
    Opperer M; Poeran J; Rasul R; Mazumdar M; Memtsoudis SG
    BMJ; 2015 Mar; 350():h1567. PubMed ID: 25817299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.
    Mutter TC; Ruth CA; Dart AB
    Cochrane Database Syst Rev; 2013 Jul; (7):CD007594. PubMed ID: 23881659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the literature inconclusive about the harm of HES? We are not sure.
    Schetz M; Shaw AD; Vincent JL
    Intensive Care Med; 2017 Oct; 43(10):1526-1528. PubMed ID: 27007103
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of high volumes of hydroxyethyl starch with acute kidney injury in elderly trauma patients.
    Leberle R; Ernstberger A; Loibl M; Merkl J; Bunz M; Creutzenberg M; Trabold B
    Injury; 2015 Jan; 46(1):105-9. PubMed ID: 25240412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular volume therapy with colloids in cardiac surgery.
    Lange M; Ertmer C; Van Aken H; Westphal M
    J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):847-55. PubMed ID: 20709570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.